Hubbell Inc (HUBB)vsWest Pharmaceutical Services Inc (WST)
HUBB
Hubbell Inc
$490.16
-0.49%
INDUSTRIALS · Cap: $25.90B
WST
West Pharmaceutical Services Inc
$322.30
-1.11%
HEALTHCARE · Cap: $23.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Hubbell Inc generates 86% more annual revenue ($6.00B vs $3.22B). WST leads profitability with a 16.9% profit margin vs 15.1%. HUBB appears more attractively valued with a PEG of 2.38. WST earns a higher WallStSmart Score of 65/100 (C+).
HUBB
Buy62
out of 100
Grade: C+
WST
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-68.2%
Fair Value
$306.75
Current Price
$490.16
$183.41 premium
Margin of Safety
-32.4%
Fair Value
$185.95
Current Price
$322.30
$136.35 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 26 in profit
Earnings expanding 56.1% YoY
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.7%
Revenue surging 21.0% year-over-year
Areas to Watch
Expensive relative to growth rate
Moderate valuation
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : HUBB
The strongest argument for HUBB centers on Return on Equity. Profitability is solid with margins at 15.1% and operating margin at 17.7%. Revenue growth of 11.1% demonstrates continued momentum.
Bull Case : WST
The strongest argument for WST centers on EPS Growth, Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 21.7%. Revenue growth of 21.0% demonstrates continued momentum.
Bear Case : HUBB
The primary concerns for HUBB are PEG Ratio, P/E Ratio.
Bear Case : WST
The primary concerns for WST are PEG Ratio, P/E Ratio. A P/E of 43.5x leaves little room for execution misses.
Key Dynamics to Monitor
HUBB profiles as a mature stock while WST is a growth play — different risk/reward profiles.
WST carries more volatility with a beta of 1.17 — expect wider price swings.
WST is growing revenue faster at 21.0% — sustainability is the question.
WST generates stronger free cash flow (47M), providing more financial flexibility.
Bottom Line
WST scores higher overall (65/100 vs 62/100), backed by strong 16.9% margins and 21.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hubbell Inc
INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA
Hubbell Incorporated designs, manufactures, and sells electrical and electronic products in the United States and internationally. The company is headquartered in Shelton, Connecticut.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other ELECTRICAL EQUIPMENT & PARTS Stocks
Want to dig deeper into these stocks?